Literature DB >> 20697050

Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP.

Orso Bugiani1, Giorgio Giaccone, Giacomina Rossi, Michela Mangieri, Raffaella Capobianco, Michela Morbin, Giulia Mazzoleni, Chiara Cupidi, Gabriella Marcon, Annarita Giovagnoli, Alberto Bizzi, Giuseppe Di Fede, Gianfranco Puoti, Francesco Carella, Andrea Salmaggi, Alessandro Romorini, Giorgio M Patruno, Mauro Magoni, Alessandro Padovani, Fabrizio Tagliavini.   

Abstract

OBJECTIVE: To report the clinical, genetic, neuroimaging, and neuropathologic studies of patients with the hereditary cerebral hemorrhage with amyloidosis linked to the APP E693K mutation.
DESIGN: Case series. Clinical details and laboratory results were collected by direct evaluation and previous medical records. DNA analysis was carried out in several affected subjects and healthy individuals. Neuropathologic examination was performed in 2 subjects.
SETTING: Southern Lombardy, Italy. Patients Individuals with and without amyloidosis in 4 unrelated Italian families (N = 37). Main Outcome Measure Genotype-phenotype relationship.
RESULTS: The affected individuals presented with recurrent headache and multiple strokes, followed by epilepsy and cognitive decline in most of them. The disease was inherited with an autosomal dominant trait and segregated with the APP E693K mutation. Neuroimaging demonstrated small to large hematomas, subarachnoid bleeding, scars with hemosiderin deposits, small infarcts, and leukoaraiosis. Amyloid-beta immunoreactivity was detected in the wall of leptomeningeal and parenchymal vessels and in the neuropil, whereas phosphorylated tau, neurofibrillary changes, and neuritic plaques were absent.
CONCLUSIONS: These findings expand the number of APP mutations linked to hereditary cerebral hemorrhage with amyloidosis, reinforcing the link between this phenotype and codon 693 of APP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697050     DOI: 10.1001/archneurol.2010.178

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Leeor S Yefet; James R Byrnes; Laura Ho; Ju Hun Yeon; Sam Filipenko; Alisa S Wolberg; Wilfred A Jefferies; Christian J Kastrup
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

3.  Alzheimer's disease: ageing-related or age-related? New hypotheses from an old debate.

Authors:  Orso Bugiani
Journal:  Neurol Sci       Date:  2011-05-13       Impact factor: 3.307

4.  Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study.

Authors:  Matthew R Elkins; Tuo Wang; Mimi Nick; Hyunil Jo; Thomas Lemmin; Stanley B Prusiner; William F DeGrado; Jan Stöhr; Mei Hong
Journal:  J Am Chem Soc       Date:  2016-07-28       Impact factor: 15.419

5.  Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.

Authors:  Aleksandra M Wojtas; Silvia S Kang; Benjamin M Olley; Maureen Gatherer; Mitsuru Shinohara; Patricia A Lozano; Chia-Chen Liu; Aishe Kurti; Kelsey E Baker; Dennis W Dickson; Mei Yue; Leonard Petrucelli; Guojun Bu; Roxana O Carare; John D Fryer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

6.  Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.

Authors:  Edward K Agyare; Sarah R Leonard; Geoffry L Curran; Caroline C Yu; Val J Lowe; Anant K Paravastu; Joseph F Poduslo; Karunya K Kandimalla
Journal:  Mol Pharm       Date:  2013-03-05       Impact factor: 4.939

Review 7.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

Review 8.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

Review 9.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

10.  Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

Authors:  L Kulic; J McAfoose; T Welt; C Tackenberg; C Späni; F Wirth; V Finder; U Konietzko; M Giese; A Eckert; K Noriaki; T Shimizu; K Murakami; K Irie; S Rasool; C Glabe; C Hock; R M Nitsch
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.